Report Thumbnail
Product Code QY0912915488RNC
Published Date 2024/7/4
QY Research
English190 PagesGlobal

Global Bacteriophage Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code QY0912915488RNC◆The Jul 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/7/4
QY Research
English 190 PagesGlobal

Global Bacteriophage Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030 ‐ Pharmaceutical_LifeSciense Market


Abstract

Summary

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The global market for Bacteriophage was estimated to be worth US$ 37 million in 2023 and is forecast to a readjusted size of US$ 121.4 million by 2030 with a CAGR of 18.8% during the forecast period 2024-2030.
Global key players of bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top three players hold a share about 23%. North America is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 29% and 23%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteriophage companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences, Inc
Pharmex Group, LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Bacteriophage in global and regional level.
Chapter 3: Detailed analysis of Bacteriophage company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bacteriophage revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

Table of Contents

  • 1 Study Coverage

    • 1.1 Bacteriophage Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Bacteriophage Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
      • 1.2.2 DsDNA Bacteriophage
      • 1.2.3 SsDNA Bacteriophage
      • 1.2.4 SsRNA Bacteriophage
      • 1.2.5 Others
    • 1.3 Market by Application
      • 1.3.1 Global Bacteriophage Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
      • 1.3.2 Animal Health
      • 1.3.3 Aquaculture
      • 1.3.4 Agriculture
      • 1.3.5 Food Industry
      • 1.3.6 Human Health
      • 1.3.7 Others
    • 1.4 Assumptions and Limitations
    • 1.5 Study Objectives
    • 1.6 Years Considered

  • 2 Executive Summary

    • 2.1 Global Bacteriophage Market Size Estimates and Forecasts
    • 2.2 Bacteriophage Market Size by Region: 2023 Versus 2030
      • 2.2.1 Global Bacteriophage Revenue by Region: 2019-2024
      • 2.2.2 Global Bacteriophage Revenue Forecast by Region (2025-2030)
      • 2.2.3 Global Bacteriophage Revenue Market Share by Region (2019-2030)

  • 3 Global Bacteriophage by Company

    • 3.1 Global Bacteriophage Revenue by Company (2019-2024)
    • 3.2 Global Bacteriophage Revenue Share by Company (2019-2024)
    • 3.3 Competitive Landscape
      • 3.3.1 Key Bacteriophage Companies around the World: Ranking by Revenue
      • 3.3.2 Global Bacteriophage Market Concentration Ratio (CR5 and HHI) & (2019-2024)
      • 3.3.3 Global Bacteriophage Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.4 Global Bacteriophage Companies Headquarters & Product Type
      • 3.4.1 Bacteriophage Companies Headquarters
      • 3.4.2 Global Bacteriophage Companies Product & Service
      • 3.4.3 Date of International Companies Enter into Bacteriophage Market
    • 3.5 Global Bacteriophage Mergers & Acquisitions, Expansion Plans

  • 4 Company Profiles

    • 4.1 NPO Microgen
      • 4.1.1 NPO Microgen Company Information
      • 4.1.2 NPO Microgen Description, Business Overview
      • 4.1.3 NPO Microgen Bacteriophage Products Offered
      • 4.1.4 NPO Microgen Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.1.5 NPO Microgen Bacteriophage Revenue by Product in 2023
      • 4.1.6 NPO Microgen Bacteriophage Revenue by Application in 2023
      • 4.1.7 NPO Microgen Bacteriophage Revenue by Geographic Area in 2023
      • 4.1.8 NPO Microgen Recent Developments
    • 4.2 Proteon Pharmaceuticals
      • 4.2.1 Proteon Pharmaceuticals Company Information
      • 4.2.2 Proteon Pharmaceuticals Description, Business Overview
      • 4.2.3 Proteon Pharmaceuticals Bacteriophage Products Offered
      • 4.2.4 Proteon Pharmaceuticals Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.2.5 Proteon Pharmaceuticals Bacteriophage Revenue by Product in 2023
      • 4.2.6 Proteon Pharmaceuticals Bacteriophage Revenue by Application in 2023
      • 4.2.7 Proteon Pharmaceuticals Bacteriophage Revenue by Geographic Area in 2023
      • 4.2.8 Proteon Pharmaceuticals Recent Developments
    • 4.3 Phagelux
      • 4.3.1 Phagelux Company Information
      • 4.3.2 Phagelux Description, Business Overview
      • 4.3.3 Phagelux Bacteriophage Products Offered
      • 4.3.4 Phagelux Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.3.5 Phagelux Bacteriophage Revenue by Product in 2023
      • 4.3.6 Phagelux Bacteriophage Revenue by Application in 2023
      • 4.3.7 Phagelux Bacteriophage Revenue by Geographic Area in 2023
      • 4.3.8 Phagelux Recent Developments
    • 4.4 Intralytix
      • 4.4.1 Intralytix Company Information
      • 4.4.2 Intralytix Description, Business Overview
      • 4.4.3 Intralytix Bacteriophage Products Offered
      • 4.4.4 Intralytix Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.4.5 Intralytix Bacteriophage Revenue by Product in 2023
      • 4.4.6 Intralytix Bacteriophage Revenue by Application in 2023
      • 4.4.7 Intralytix Bacteriophage Revenue by Geographic Area in 2023
      • 4.4.8 Intralytix Recent Developments
    • 4.5 Micreos
      • 4.5.1 Micreos Company Information
      • 4.5.2 Micreos Description, Business Overview
      • 4.5.3 Micreos Bacteriophage Products Offered
      • 4.5.4 Micreos Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.5.5 Micreos Bacteriophage Revenue by Product in 2023
      • 4.5.6 Micreos Bacteriophage Revenue by Application in 2023
      • 4.5.7 Micreos Bacteriophage Revenue by Geographic Area in 2023
      • 4.5.8 Micreos Recent Developments
    • 4.6 Eliava BioPreparations
      • 4.6.1 Eliava BioPreparations Company Information
      • 4.6.2 Eliava BioPreparations Description, Business Overview
      • 4.6.3 Eliava BioPreparations Bacteriophage Products Offered
      • 4.6.4 Eliava BioPreparations Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.6.5 Eliava BioPreparations Bacteriophage Revenue by Product in 2023
      • 4.6.6 Eliava BioPreparations Bacteriophage Revenue by Application in 2023
      • 4.6.7 Eliava BioPreparations Bacteriophage Revenue by Geographic Area in 2023
      • 4.6.8 Eliava BioPreparations Recent Development
    • 4.7 Locus Biosciences, Inc
      • 4.7.1 Locus Biosciences, Inc Company Information
      • 4.7.2 Locus Biosciences, Inc Description, Business Overview
      • 4.7.3 Locus Biosciences, Inc Bacteriophage Products Offered
      • 4.7.4 Locus Biosciences, Inc Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.7.5 Locus Biosciences, Inc Bacteriophage Revenue by Product in 2023
      • 4.7.6 Locus Biosciences, Inc Bacteriophage Revenue by Application in 2023
      • 4.7.7 Locus Biosciences, Inc Bacteriophage Revenue by Geographic Area in 2023
      • 4.7.8 Locus Biosciences, Inc Recent Development
    • 4.8 Pharmex Group, LLC
      • 4.8.1 Pharmex Group, LLC Company Information
      • 4.8.2 Pharmex Group, LLC Description, Business Overview
      • 4.8.3 Pharmex Group, LLC Bacteriophage Products Offered
      • 4.8.4 Pharmex Group, LLC Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.8.5 Pharmex Group, LLC Bacteriophage Revenue by Product in 2023
      • 4.8.6 Pharmex Group, LLC Bacteriophage Revenue by Application in 2023
      • 4.8.7 Pharmex Group, LLC Bacteriophage Revenue by Geographic Area in 2023
      • 4.8.8 Pharmex Group, LLC Recent Development
    • 4.9 Pherecydes Pharma
      • 4.9.1 Pherecydes Pharma Company Information
      • 4.9.2 Pherecydes Pharma Description, Business Overview
      • 4.9.3 Pherecydes Pharma Bacteriophage Products Offered
      • 4.9.4 Pherecydes Pharma Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.9.5 Pherecydes Pharma Bacteriophage Revenue by Product in 2023
      • 4.9.6 Pherecydes Pharma Bacteriophage Revenue by Application in 2023
      • 4.9.7 Pherecydes Pharma Bacteriophage Revenue by Geographic Area in 2023
      • 4.9.8 Pherecydes Pharma Recent Development
    • 4.10 APS Biocontrol Ltd. (APS)
      • 4.10.1 APS Biocontrol Ltd. (APS) Company Information
      • 4.10.2 APS Biocontrol Ltd. (APS) Description, Business Overview
      • 4.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Products Offered
      • 4.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.10.5 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Product in 2023
      • 4.10.6 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Application in 2023
      • 4.10.7 APS Biocontrol Ltd. (APS) Bacteriophage Revenue by Geographic Area in 2023
      • 4.10.8 APS Biocontrol Ltd. (APS) Recent Development
    • 4.11 Qingdao Phagepharm Bio-tech
      • 4.11.1 Qingdao Phagepharm Bio-tech Company Information
      • 4.11.2 Qingdao Phagepharm Bio-tech Description, Business Overview
      • 4.11.3 Qingdao Phagepharm Bio-tech Bacteriophage Products Offered
      • 4.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.11.5 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Product in 2023
      • 4.11.6 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Application in 2023
      • 4.11.7 Qingdao Phagepharm Bio-tech Bacteriophage Revenue by Geographic Area in 2023
      • 4.11.8 Qingdao Phagepharm Bio-tech Recent Development
    • 4.12 Fixed-Phage Limited
      • 4.12.1 Fixed-Phage Limited Company Information
      • 4.12.2 Fixed-Phage Limited Description, Business Overview
      • 4.12.3 Fixed-Phage Limited Bacteriophage Products Offered
      • 4.12.4 Fixed-Phage Limited Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.12.5 Fixed-Phage Limited Bacteriophage Revenue by Product in 2023
      • 4.12.6 Fixed-Phage Limited Bacteriophage Revenue by Application in 2023
      • 4.12.7 Fixed-Phage Limited Bacteriophage Revenue by Geographic Area in 2023
      • 4.12.8 Fixed-Phage Limited Recent Development
    • 4.13 Zeptometrix
      • 4.13.1 Zeptometrix Company Information
      • 4.13.2 Zeptometrix Description, Business Overview
      • 4.13.3 Zeptometrix Bacteriophage Products Offered
      • 4.13.4 Zeptometrix Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.13.5 Zeptometrix Bacteriophage Revenue by Product in 2023
      • 4.13.6 Zeptometrix Bacteriophage Revenue by Application in 2023
      • 4.13.7 Zeptometrix Bacteriophage Revenue by Geographic Area in 2023
      • 4.13.8 Zeptometrix Recent Development
    • 4.14 Phage International, Inc.
      • 4.14.1 Phage International, Inc. Company Information
      • 4.14.2 Phage International, Inc. Description, Business Overview
      • 4.14.3 Phage International, Inc. Bacteriophage Products Offered
      • 4.14.4 Phage International, Inc. Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.14.5 Phage International, Inc. Bacteriophage Revenue by Product in 2023
      • 4.14.6 Phage International, Inc. Bacteriophage Revenue by Application in 2023
      • 4.14.7 Phage International, Inc. Bacteriophage Revenue by Geographic Area in 2023
      • 4.14.8 Phage International, Inc. Recent Development
    • 4.15 MicroMir
      • 4.15.1 MicroMir Company Information
      • 4.15.2 MicroMir Description, Business Overview
      • 4.15.3 MicroMir Bacteriophage Products Offered
      • 4.15.4 MicroMir Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.15.5 MicroMir Bacteriophage Revenue by Product in 2023
      • 4.15.6 MicroMir Bacteriophage Revenue by Application in 2023
      • 4.15.7 MicroMir Bacteriophage Revenue by Geographic Area in 2023
      • 4.15.8 MicroMir Recent Development
    • 4.16 iNtODEWORLD, Inc.
      • 4.16.1 iNtODEWORLD, Inc. Company Information
      • 4.16.2 iNtODEWORLD, Inc. Description, Business Overview
      • 4.16.3 iNtODEWORLD, Inc. Bacteriophage Products Offered
      • 4.16.4 iNtODEWORLD, Inc. Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.16.5 iNtODEWORLD, Inc. Bacteriophage Revenue by Product in 2023
      • 4.16.6 iNtODEWORLD, Inc. Bacteriophage Revenue by Application in 2023
      • 4.16.7 iNtODEWORLD, Inc. Bacteriophage Revenue by Geographic Area in 2023
      • 4.16.8 iNtODEWORLD, Inc. Recent Development
    • 4.17 NEXTBIOTICS
      • 4.17.1 NEXTBIOTICS Company Information
      • 4.17.2 NEXTBIOTICS Description, Business Overview
      • 4.17.3 NEXTBIOTICS Bacteriophage Products Offered
      • 4.17.4 NEXTBIOTICS Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.17.5 NEXTBIOTICS Bacteriophage Revenue by Product in 2023
      • 4.17.6 NEXTBIOTICS Bacteriophage Revenue by Application in 2023
      • 4.17.7 NEXTBIOTICS Bacteriophage Revenue by Geographic Area in 2023
      • 4.17.8 NEXTBIOTICS Recent Development
    • 4.18 Armata Pharmaceuticals, Inc.
      • 4.18.1 Armata Pharmaceuticals, Inc. Company Information
      • 4.18.2 Armata Pharmaceuticals, Inc. Description, Business Overview
      • 4.18.3 Armata Pharmaceuticals, Inc. Bacteriophage Products Offered
      • 4.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.18.5 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Product in 2023
      • 4.18.6 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Application in 2023
      • 4.18.7 Armata Pharmaceuticals, Inc. Bacteriophage Revenue by Geographic Area in 2023
      • 4.18.8 Armata Pharmaceuticals, Inc. Recent Development
    • 4.19 Innophage
      • 4.19.1 Innophage Company Information
      • 4.19.2 Innophage Description, Business Overview
      • 4.19.3 Innophage Bacteriophage Products Offered
      • 4.19.4 Innophage Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.19.5 Innophage Bacteriophage Revenue by Product in 2023
      • 4.19.6 Innophage Bacteriophage Revenue by Application in 2023
      • 4.19.7 Innophage Bacteriophage Revenue by Geographic Area in 2023
      • 4.19.8 Innophage Recent Development
    • 4.20 Adaptive Phage Therapeutics
      • 4.20.1 Adaptive Phage Therapeutics Company Information
      • 4.20.2 Adaptive Phage Therapeutics Description, Business Overview
      • 4.20.3 Adaptive Phage Therapeutics Bacteriophage Products Offered
      • 4.20.4 Adaptive Phage Therapeutics Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.20.5 Adaptive Phage Therapeutics Bacteriophage Revenue by Product in 2023
      • 4.20.6 Adaptive Phage Therapeutics Bacteriophage Revenue by Application in 2023
      • 4.20.7 Adaptive Phage Therapeutics Bacteriophage Revenue by Geographic Area in 2023
      • 4.20.8 Adaptive Phage Therapeutics Recent Development
    • 4.21 TechnoPhage
      • 4.21.1 TechnoPhage Company Information
      • 4.21.2 TechnoPhage Description, Business Overview
      • 4.21.3 TechnoPhage Bacteriophage Products Offered
      • 4.21.4 TechnoPhage Bacteriophage Revenue and Gross Margin (2019-2024)
      • 4.21.5 TechnoPhage Bacteriophage Revenue by Product in 2023
      • 4.21.6 TechnoPhage Bacteriophage Revenue by Application in 2023
      • 4.21.7 TechnoPhage Bacteriophage Revenue by Geographic Area in 2023
      • 4.21.8 TechnoPhage Recent Development

  • 5 Breakdown Data by Type

    • 5.1 Global Bacteriophage Revenue by Type (2019-2024)
    • 5.2 Global Bacteriophage Revenue Forecast by Type (2025-2030)
    • 5.3 Bacteriophage Revenue Market Share by Type (2019-2030)

  • 6 Breakdown Data by Application

    • 6.1 Global Bacteriophage Revenue by Application (2019-2024)
    • 6.2 Global Bacteriophage Revenue Forecast by Application (2025-2030)
    • 6.3 Bacteriophage Revenue Market Share by Application (2019-2030)

  • 7 North America

    • 7.1 North America Bacteriophage Market Size YoY Growth 2019-2030
    • 7.2 North America Bacteriophage Market Facts & Figures by Country (2019-2030)
    • 7.3 North America Bacteriophage Revenue by Type (2019-2024)
    • 7.4 North America Bacteriophage Revenue by Application (2019-2024)

  • 8 Asia-Pacific

    • 8.1 Asia-Pacific Bacteriophage Market Size YoY Growth 2019-2030
    • 8.2 Asia-Pacific Bacteriophage Market Facts & Figures by Region (2019-2030)
    • 8.3 Asia-Pacific Bacteriophage Revenue by Type (2019-2024)
    • 8.4 Asia-Pacific Bacteriophage Revenue by Application (2019-2024)

  • 9 Europe

    • 9.1 Europe Bacteriophage Market Size YoY Growth 2019-2030
    • 9.2 Europe Bacteriophage Market Facts & Figures by Country (2019-2030)
    • 9.3 Europe Bacteriophage Revenue by Type (2019-2024)
    • 9.4 Europe Bacteriophage Revenue by Application (2019-2024)

  • 10 Latin America

    • 10.1 Latin America Bacteriophage Market Size YoY Growth 2019-2030
    • 10.2 Latin America Bacteriophage Market Facts & Figures by Country (2019-2030)
    • 10.3 Latin America Bacteriophage Revenue by Type (2019-2024)
    • 10.4 Latin America Bacteriophage Revenue by Application (2019-2024)

  • 11 Middle East and Africa

    • 11.1 Middle East and Africa Bacteriophage Market Size YoY Growth 2019-2030
    • 11.2 Middle East and Africa Bacteriophage Market Facts & Figures by Country (2019-2030)
    • 11.3 Middle East and Africa Bacteriophage Revenue by Type (2019-2024)
    • 11.4 Middle East and Africa Bacteriophage Revenue by Application (2019-2024)

  • 12 Supply Chain and Sales Channel Analysis

    • 12.1 Bacteriophage Supply Chain Analysis
    • 12.2 Bacteriophage Key Raw Materials and Upstream Suppliers
    • 12.3 Bacteriophage Clients Analysis
    • 12.4 Bacteriophage Sales Channel and Sales Model Analysis
      • 12.4.1 Bacteriophage Distribution Channel Analysis: Indirect Sales VS Direct Sales
      • 12.4.2 Bacteriophage Distribution Channel Analysis: Online Sales VS Offline Sales
      • 12.4.3 Bacteriophage Distributors

  • 13 Market Dynamics

    • 13.1 Bacteriophage Industry Trends
    • 13.2 Bacteriophage Market Drivers
    • 13.3 Bacteriophage Market Challenges
    • 13.4 Bacteriophage Market Restraints

  • 14 Research Findings and Conclusion

  • 15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details
    • 15.3 Disclaimer
USD 5,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.